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A B S T R A C T   
Background: Multiple sclerosis (MS) is characterized by two neuropathological key aspects: inflammation and 
neurodegeneration. Clinical studies support a prospective link between psychological stress and subsequent 
inflammatory disease activity. However, it is unknown if a similar link exists for grey matter (GM) degeneration 
as the key driver of irreversible disability. 
Methods: We tested whether neural network activity triggered in a psychological fMRI stress paradigm (a mental 
arithmetic task including social evaluation) conducted at a baseline time point predicts future GM atrophy in 25 
persons with MS (14 females). Atrophy was determined between the baseline and a follow-up time point with a 
median delay of 1012 (Rg: 717–1439) days. Additionally, atrophy was assessed in 22 healthy subjects (13 fe-
males; median delay 771 [Rg: 740–908] days between baseline and follow-up) for comparison. 
Results: An analysis of longitudinal atrophy in patients revealed GM loss in frontal, parietal, and cerebellar areas. 
Cerebellar atrophy was more pronounced in patients than controls. Future parietal and cerebellar atrophy could 
be predicted based on activity of two networks. Perceived psychological stress was negatively related to future 
parietal atrophy in patients and activity of the network predictive of parietal atrophy was positively linked to 
perceived stress. 
Conclusions: We have shown that blunted neural and psychological stress processing have a detrimental effect on 
the course of MS and are interrelated. Together with research showing that psychological and neural stress 
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processing can be altered through interventions, our findings suggest that stress processing might constitute an 
important modifiable disease factor.   
1. Introduction 
Multiple sclerosis (MS) is a demyelinating autoimmune disorder of 
the central nervous system characterized by an inflammatory and 
neurodegenerative component (Reich et al., 2018). The clinical pheno-
type can comprise sensorimotor, cognitive and neuropsychiatric symp-
toms such as depression and fatigue (Compston and Coles, 2008). 
Consistently, a role of psychological stress in the pathobiology of the 
disease has been assumed since the first description of MS by Charcot 
(1877) and this assumption is now supported by epidemiological and 
clinical studies. A Swedish cohort study including 106,464 persons with 
stress-related disorders (e.g., Post-Traumatic Stress Disorder) and 1,064, 
640 without showed that these disorders increase the risk for later 
development of autoimmune disorders including MS (Song et al., 2018). 
Prospective clinical studies found an association between stressful 
events and subsequent symptom exacerbation, relapses and inflamma-
tory activity (Mohr et al., 2004; Golan et al., 2008). Finally, alleviation 
of stress has a buffering effect on MS activity as participation in 
stress-management programs reduced the risk of developing new MRI 
lesions in a randomized controlled trial (Mohr et al., 2012). 
Despite these clinico-epidemiological findings, not much is known 
about the biological mechanisms connecting psychological stress and 
MS. Specifically, although pharmacological challenge studies including 
our own have revealed associations between peripheral stress systems 
and disease activity, the role of psychological stress for this association 
was not addressed by this work (Gold et al., 2005; Kern et al., 2013). 
Moreover, although we could show in a cross-sectional neuroimaging 
study employing a stress paradigm (Weygandt et al., 2016) that insular 
activity reflects the clinical disability of persons with MS (pwMS) and 
that activity in overlapping cerebellar regions of pwMS and healthy 
controls (HCs) was linked to the grey matter (GM) fraction in both 
groups, this study did not clarify the role of neurocognitive stress pro-
cessing for future GM degeneration. 
Evaluating this role, however, might be crucial as i. GM atrophy is 
the main driver of irreversible disability progression in MS (Confavreux 
and Vukusic, 2006; Geurts et al., 2012; Eshaghi et al., 2018), ii. no 
convincing pharmacological treatment currently exists to halt GM at-
rophy (Kalincik, 2017), and iii. neural stress processing is modifiable 
through cognitive interventions (Sinha et al., 2016). To test a link be-
tween stress and future GM atrophy in MS, we thus investigated whether 
neural network activity triggered by a stress paradigm (i.e., a mental 
arithmetic task comprising social evaluation and ratings of perceived 
stress) conducted at a baseline time point (‘T0’) predicts GM atrophy 
accumulated between baseline and a follow-up time point (‘T1’) roughly 
1000 days later. Specifically, we tested the hypotheses that perceived 
psychological and neural network stress responses predict the degree of 
longitudinal GM volume loss in each region subject to atrophy in pa-
tients. Moreover, we tested the hypotheses that each neural network 
significantly predicting longitudinal GM atrophy is significantly related 
to perceived psychological stress. 
2. Materials and methods 
2.1. Participants 
The present study is a longitudinal extension of our cross-sectional 
study (Weygandt et al., 2016) from which the baseline (T0) pwMS 
data (i.e., anatomical and functional MRI, heart rate, perceived stress, 
and salivary cortisol) and T0 fMRI stress data of a group of 21 HCs 
(referred to as ‘fMRI control group’ in the following) were taken. To 
gather follow-up anatomical MRI scans, all pwMS participating in 
Weygandt et al. (2016) were re-invited in the present study for a 
follow-up visit (T1). Twenty-six of the 36 pwMS measured at baseline 
agreed to participate. All scans were acquired at the Berlin Center for 
Advanced Neuroimaging at Charité – Universitätsmedizin Berlin. The 
inclusion criteria at T1 comprised i. a diagnosis of relapsing-remitting or 
secondary progressive MS according to the McDonald Criteria 2017 
(Thompson et al., 2017), ii. stable disease-modifying treatment for at 
least six months or no disease-modifying treatment, iii. no neurologic 
diseases other than MS and iv. age ≥18 years. Exclusion criteria were: 
Pregnancy, mental or addictive disorders, neurologic diseases other than 
MS, acute MS relapses or infections, MRI contraindications and poor 
MRI image quality. The visual inspection of anatomical MRI scans 
revealed low data quality for one patient. Other criteria did not apply. 
Experienced neurologists examined and diagnosed all participating pa-
tients. Clinical disability was assessed using the Expanded Disability 
Status Scale (EDSS; Kurtzke, 1983). Participants’ study visits were 
approved by the research ethics committee of Charité – Uni-
versitätsmedizin Berlin (EA1/182/10, amendment V). 
Additionally, we analyzed longitudinal structural MRI (sMRI) data 
from a group of 22 other HCs (not yet presented elsewhere and referred 
to as ‘sMRI control group’) which were originally obtained in a natural 
history cohort from the University Medical Center Hamburg-Eppendorf 
in Hamburg including clinical and MRI visits at baseline (T0) and at 
around 24 months (T1). The inclusion criteria were i. an age between 18 
and 65, ii. no evidence of medical illness or substance abuse that may 
affect cognitive functioning, and iii. no psychiatric or neurological dis-
eases (based on medical history and physical exam). Exclusion criteria 
were MRI contraindications and poor MRI image quality. As no exclu-
sion criteria applied, all 22 HCs were included. Study visits in Hamburg 
were approved by the ethics committee of the Hamburg Medical Asso-
ciation (PV4356). Written consent was obtained from all participants 
according to the Declaration of Helsinki. 
2.2. Experimental stress paradigm 
The fMRI stress task is delineated in Fig. 1. 
2.3. MRI sequences 
MR images of pwMS at T0 and T1 and of the 21 HCs from the fMRI 
control group at T0 were acquired with a 3 T whole-body tomograph 
(Magnetom Trio, Siemens, Erlangen, Germany) using a standard 12- 
channel head coil. To acquire fMRI scans, we used a pseudo- 
continuous Arterial-Spin Labeling (ASL) Echo-Planar Imaging (EPI) 
sequence (Wang et al., 2005). In addition, two spin-echo EPI reference 
volumes with opposite phase encoding directions (anterior to posterior, 
posterior to anterior) were acquired in advance to the Rest and Stress 
fMRI measurements to facilitate B0-unwarping of fMRI images. 
Anatomical images were acquired with T1-weighted and T2-weighted 
sequences. Anatomical T1-weighted MRI scans of the HCs from the 
sMRI control group were acquired with a 3 T whole-body tomograph 
(Magnetom Skyra, Siemens, Erlangen, Germany) and a standard 
32-channel head coil. See supplementary methods for details. 
2.4. MRI preprocessing 
2.4.1. Anatomical images 
Preprocessing of anatomical MRI data comprised i. a manual lesion 
mapping procedure, ii. segmentation of T1-weighted anatomical images, 
iii. determination of a GM group mask for fMRI analyses, and iv. a 
determination of the volume of 122 GM regions defined by a 
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neuroanatomical atlas for T0 and T1. In the latter step, the volume of 
each individual region, participant, and both time points was computed 
based on the spatial brain segmentation procedure that enables alloca-
tion of intracranial voxel coordinates to one of three tissue classes: GM, 
white matter, and cerebrospinal fluid. After the number of GM voxels 
was determined for each atlas region, we computed the regional GM 
volume by multiplying the number of voxels by the volume of a voxel in 
mm3. Regional volume data were then entered as criteria into our group 
MRI analysis. Please see supplementary methods for details. 
2.4.2. Functional images 
In this study, we evaluated fMRI images that were already analyzed 
in Weygandt et al. (2016). Preprocessing of these images comprised six 
steps, i.e., i. co-registration of perfusion fMRI scans to spin-echo EPI 
volumes acquired for B0-unwarping, ii. B0-unwarping of fMRI scans, iii. 
coregistration of fMRI scans to anatomical T1-weighted scans, iv. spatial 
smoothing of fMRI scans, v. computation of voxel images assessing the 
average cerebral blood flow (CBF; ml/100 g/min) for the (final) 8 min of 
the Rest and the Stress measurement based on control-label pairs. 
Finally, in step vi. we used the mapping parameters computed during 
segmentation of T1-weighted scans to register the average CBF maps of 
both fMRI conditions to the MNI standard space. These spatially 
normalized CBF maps (voxel size of 3 ⋅ 3 ⋅ 3 mm3) computed for each 
patient and both fMRI conditions separately entered the fMRI group 
analysis. See supplementary methods for details. 
2.5. Statistical analyses 
2.5.1. Longitudinal GM atrophy 
We conducted two subanalyses to evaluate longitudinal atrophy in 
pwMS (and HCs of the sMRI control group) in 2.5.1. The main goal of 
2.5.1, which was addressed in the first subanalysis, was to identify GM 
areas (among 122 regions included in the neuroanatomical atlas) that 
were characterized by longitudinal volume loss in the period from T0 to 
T1 in MS patients (i.e., areas showing a main effect of time in pwMS). In 
the second subanalysis, conducted to clarify whether volume loss of 
areas putatively found in the first subanalysis was specific for MS, we 
evaluated in which of these regions the impact of time on volume loss 
differed between patients and controls (interaction effect of time and 
group). In both analyses, linear-mixed effects (LME) regression (cf. 
Weygandt et al., 2019) was applied using the FITLMEMATRIX algorithm 
implemented in Matlab (2014a) (MathWorks, Natick, Massachusetts, 
USA) to evaluate longitudinal effects. 
In the first analysis, the regressor of interest coded zeros for the T0 
measurement and the number of days after T0 for T1. Sex, age, pro-
gressive MS (y/n), and a fixed and random intercept were modelled as 
covariates of no interest. We report regions with GM volume reductions 
significant according to a Family-Wise Error (FWE)-corrected threshold 
Fig. 1. Mental arithmetic stress paradigm which was derived from Wang et al. (2005). In the first of five stages evaluated in this study (‘A Pre-Rest’), participants 
rated the experienced degree of distress, relaxation, frustration, and anxiety on a 9-point self-report scale presented on a projection screen inside the scanner with 
MRI-compatible button boxes. Options ranged from ‘Gar nicht’ (‘not at all’) depicted at the leftmost position of the scale to ‘Sehr stark’ (‘very strong’) depicted on the 
rightmost position. In the second stage (‘B Rest’), we conducted a baseline ASL fMRI scan during which the participants were instructed to focus on a fixation cross. 
Following a second self-report (‘C Pre-Stress’), we conducted the main fMRI stress measurement (‘D Stress’). During this stage, participants were asked to perform a 
series of subtraction tasks, i.e. ‘operand X minus operand Y’. In each trial, a participant had to select the correct result from four numbers depicted below operands X 
and Y. The start value for X was 43 521 across all participants. Operand Y was randomly determined in each trial and ranged from 1 to 99. The stress block was 
divided in two sub-stages, an adaptation stage D(i; ≤ 4 min duration) and a performance stage D(ii; lasting for the remaining time of the total 12 min duration of D). 
In D(i), participants had 8 s per trial to choose a result and response times were recorded. In the case of a correct result, the difference X minus Y was used as operand 
X in the next trial. Otherwise, operand X remained unchanged. When 10 correct answers were given or when the 4-min. adaption stage was over, D(i) ended and D(ii) 
began without announcement. D(ii) differed from D(i) in three important aspects. Firstly, the time provided for each trial was adjusted based on arithmetic per-
formance (i.e. starting at 8 s, which was decreased or increased by ten percent depending on response accuracy in preceding trials). Secondly, we provided feedback 
by means of school grades ranging from ‘1 – Sehr gut’ (‘very good’) down to ‘5 – Ungenügend’ (‘insufficient’) depending on response time for correct trials during the 
adaptation stage. Finally, participants had to start over again with X = 43 521 in case of false or too slow answers. After the stress block, participants rated their 
perceived stress level for a third time (‘E Post-Stress’). We measured heart rate with a pulse oximeter (see Supplement for details) during both fMRI blocks (B, D) and 
computed the task load as the average duration of inter-trial intervals during the last 8 min of stage D. Task load served as covariate of no interest for statistical group 
analyses. Moreover, salivary cortisol was measured during all three rating stages (A, C, and E; see Supplement for details). Prior to the start of the MRI session, 
patients were informed about their participation in a mental arithmetic task and the feedback they would receive comparing their performance to performance 
parameters established in the general population. After the experiment, we explained to them that feedback was generated based on their arithmetic performance in 
the adaptation stage. The figure was adapted from Weygandt et al. (2016). 
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(αFWE = 0.05) for two-sided tests computed by dividing the false positive 
rate for a single test of 0.05 by the number of regions in the atlas. 
In the second (factorial) analysis, the interaction regressor testing the 
disease-specificity of the temporal dynamic of regional volume loss was 
computed as the element-wise product of the two main effect regressors 
of group and time. Both main effect regressors, sex, age, and fixed and 
random intercepts were included in the LME model as covariates of no 
interest. Again, we applied an FWE-corrected significance threshold for 
two-sided tests (i.e. 0.05 divided by the number of regions with signif-
icant GM loss in patients). The false positive rate of effects of interest in 
both LME analyses (and all other statistical tests conducted in this work) 
was evaluated with permutation testing (10 000 permutations of the 
regressor of interest; cf. [20]). Compared with parametric procedures, 
permutation techniques are much more robust as they do not rely on the 
fulfilment of distributional assumptions (Good, 2005). Please note that 
we report results obtained in the second/interaction analysis for the 
main effect of group on regional GM volume in all 122 areas in the 
Supplement to highlight areas affected by MS atrophy independent of 
the temporal dynamics of this process. 
2.5.2. Predicting future GM atrophy in MS based on perceived stress 
The main effect of perceived psychological stress on longitudinal 
atrophy in areas with significant atrophy in pwMS as revealed by the 
above analysis was tested with robust linear regression (using a bisquare 
M-estimator) implemented in the ROBUSTFIT Matlab 2014a algorithm. 
Robust regression using bisquare M-estimators is much less affected by 
outliers than standard (i.e., ordinary least square) regression and has 
consistently been proven to increase the power of statistical tests (Wager 
et al., 2005; Fox and Weisberg, 2019). The time between T0 and T1 in 
days, sex, age, task load, the presence of progressive MS (y/n), and GM 
volume of the respective region at T0 served as covariates of no interest 
(in the framework of this study). We hypothesized that perceived psy-
chological stress predicts the degree of longitudinal GM volume loss in 
each GM region subject to longitudinal atrophy in patients. Each of these 
individual hypotheses was tested with a significance threshold of α =
0.05 for two-sided tests. Permutation testing was used for inference (10 
000 permutations). 
An analysis of psychophysiological stress task responses evaluating 
the basic suitability of our mental arithmetic task to induce stress in 
terms of perceived stress, heart rate, and salivary cortisol can be found in 
the Supplement. 
2.5.3. Predicting future GM atrophy in MS based on neural stress responses 
Here, we tested whether we can use task-induced activity changes of 
neural networks to predict the longitudinal volume variations of GM 
areas subject to atrophy in pwMS. For this purpose, we determined 
neural networks composed by brain regions whose activity was strongly 
correlated across pwMS during the stress stage. Specifically, we first 
computed the average CBF for each pwMS and each GM region con-
tained in the atlas for the resting and stress stage separately. Then, we 
removed each patient’s overall signal mean of a given task stage from 
each regions’ task stage mean signal (‘centering’). Next, we used Sin-
gular Value Decomposition (SVD) to compute a small set of 25 hidden 
variables (Principal Components; PCs; see e.g., 24, 25) that reflect the 
shared characteristic variation underlying the signals of individual GM 
regions contributing to a given network during the stress stage across 
pwMS. Each of these hidden variables represents one network and en-
codes the activity of the given network for a patient as a single number. 
In the next step, we used the centered regional activity signals of the 
resting stage to determine these hidden variables as activity markers of 
the networks during rest. Finally, we subtracted the network activity 
scores computed for the resting from those of the stress stage to deter-
mine stress-induced activity changes for each pwMS. For further details 
(including information on the permutation-based determination of GM 
atlas regions contributing significantly to the different networks), see 
supplementary methods. 
After neural network activity parameters were determined, we 
entered the differential stress processing markers as covariates of in-
terest into robust regression models for the prediction of future GM 
volume loss. Time between T0 and T1 in days, sex, age, the presence of 
progressive MS (y/n), task load, GM volume of the respective region at 
T0 were included in the model as covariates of no interest. For each of 
the five GM areas subject to atrophy in patients, we computed one robust 
regression model for the differential stress responses of each of the 25 
networks. In line with our hypotheses that the degree of longitudinal 
atrophy of each of the five GM areas subject to atrophy in patients can be 
predicted by neural network stress responses, we accounted for multiple 
tests by applying an FWE-corrected significance threshold for two-sided 
tests computed as the false positive rate of a single test (0.05) divided by 
the number of PCs determined. Again, permutation testing was used for 
inference (10 000 permutations). 
An analysis of stress network activity differences between the pwMS 
and participants in the fMRI control group as well as an analysis testing 
whether future atrophy in pwMS can be predicted based on stress- 
related cortisol release can be found in the Supplement. 
2.5.4. Perceived stress and neural stress responses in MS 
We tested the hypotheses that each neural network whose differen-
tial stress response predicts future atrophy in patients also predicts the 
perceived stress ratings (i.e., post-minus pre-stress). For this purpose, 
one robust regression model was computed for the activity of each 
network fulfilling this criterion as covariate of interest. Sex, age, the 
presence of progressive MS (y/n), and task load were included as 
covariates of no interest. We applied an FWE-corrected threshold for 
two-sided tests (i.e., 0.05 divided by the number of atrophy-predictive 
networks). Permutation testing (10 000 permutations) was used for 
inference. 
Finally, an analysis testing whether stress-related cortisol release is 
associated to atrophy-predictive neural network activity and perceived 
stress can be found in the Supplement. 
3. Results 
3.1. Demographic and clinical participant characteristics 
Twenty-five persons with (19 relapsing-remitting; 6 secondary pro-
gressive) MS were included in the study, 22 in the sMRI control group, 
and 21 HCs in the fMRI control group. At T0, 18 patients received a 
disease modifying treatment (4 fumarate, 5 β-interferons, 4 glatiramer 
acetate, 4 fingolimod, and 1 teriflunomide). The median disease dura-
tion in patients at T0 relative to the onset of first symptoms was 9.72 (Rg 
= 1.30–33.54) years. The median clinical-severity assessed with the 
EDSS (Kurtzke, 1983) was 3.5 at both visits (T0: Rg = 1–6; T1: Rg =
0–6). See Table 1 below and supplementary results for further de-
mographic and clinical participant characteristics. 
Table 1 
Demographic and clinical participant characteristics. False positive rate of test 
statistics was computed with permutation testing (10 000 permutations). Ab-
breviations: HSD – high school diploma.  
Group Sex (f/m) Age (yrs) HSD(y/n) Follow-up interval 
(days)  
# MD RG # MD RG 
MS 14/11 5027–62 15/10 1012 717–1439 
HC - sMRI 13/9 44 
30–57 
13/9 771 740 - 908 
HC - fMRI 13/8 5125–64 16/5   
χ2 p t p χ2 p t p 




2.41 0.021 0.00 >
0.999 
6.92 < 10− 4 
MS vs. HC - 
fMRI 
0.160.765 − 0.10 
0.926 
1.36 0.344   
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3.2. Longitudinal GM volume loss 
The LME analyses testing the main effect of time on GM volume 
across all 122 regions in the atlas in patients identified five regions with 
significant volume loss according to the FWE-corrected threshold (αFWE 
= 0.05/122 = 4.1 ∙ 10− 4). In particular, right (t = − 6.9, p < 10− 4) and 
left middle frontal gyrus (t = − 5.8, p < 10− 4), right cerebellum exterior 
(t = − 5.7, p < 10− 4), right superior parietal (t = − 5.1, p < 10− 4) and left 
superior frontal areas (t = − 4.7, p = 1 ∙ 10− 4) were affected (Fig. 2). An 
evaluation of the interaction effect of time and group or the disease- 
specificity of the temporal dynamic of regional volume loss in these 
five regions respectively showed that atrophy in the right cerebellum 
exterior was significantly more pronounced in patients than controls (t 
= − 2.9, p = 0.005). 
3.3. Predicting future GM atrophy in MS based on perceived stress 
Testing the association between perceived stress ratings (post-minus 
pre-stress) and longitudinal volume loss for the five regions subject to 
atrophy in pwMS showed that psychological insensitivity to stress was 
coupled to stronger longitudinal atrophy in the right superior parietal 
lobule. In other words, higher differential stress ratings were positively 
associated to the volume difference for T1 – T0 in this area (t = 3.1, p =
0.007). 
3.4. Predicting future GM atrophy in MS based on neural stress responses 
This analysis showed that differential stress activity of two networks 
predicted future GM loss in two of the five regions. In particular, 
following the FWE-corrected threshold (αFWE = 0.05/25 = 0.002), 
stress-induced activity of the 18th network (comprising a variety of 
prefrontal brain areas) was negatively associated with atrophy (i.e., 
positively with the volume difference T1 – T0; t = 5.1, p = < 10− 4) in 
right superior parietal lobule. Furthermore, the 22nd network including 
a variety of prefronto-limbic areas was positively linked to future vol-
ume loss in the right exterior cerebellum (i.e., negatively to the 
Fig. 2. Longitudinal GM atrophy. (a) On the left side, the computation of longitudinal GM volume variations is illustrated for an arbitrary person with multiple 
sclerosis and selected axial slices of the right exterior cerebellum. Specifically, superimposed on the native anatomical T1-weighted images of this patient, red (green) 
areas highlight voxels classified as right exterior cerebellum at T0 (T1) by the procedure used for volume computation in our analyses. Yellow areas were classified as 
right exterior cerebellum voxels at both time points. (b) Regions with significant longitudinal GM volume reductions across pwMS. In all subgraphs in (b), the 
regional volumes were corrected for covariates of no interest. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web 
version of this article.) 
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difference T1 – T0; t = − 4.4, p = 3 ∙ 10− 4; Fig. 3). 
3.5. Perceived stress and neural stress responses in MS 
This analysis showed that activity of one of the two networks pre-
dicting longitudinal atrophy was related to the difference of stress rat-
ings for the post-minus pre-stress stage. Specifically, following the FWE- 
corrected significance threshold (αFWE = 0.05/2 = 0.025), activity of the 
18th network was positively linked to psychological stress (t = 4.7, p = 5 
∙ 10− 4; Fig. 4). 
4. Discussion 
We investigated whether neurocognitive stress processing during 
exposure to mild psychological stress predicts future GM atrophy in 
persons with MS accumulated over a period of roughly 1000 days. 
Four main analyses were conducted. In the first, we evaluated 
anatomical MRI data to identify GM regions affected by longitudinal 
atrophy in pwMS as targets for our predictive analyses and compared the 
patients’ longitudinal atrophy to that of controls to evaluate its disease- 
specificity. We could show a significant loss in five regions, i.e., in both 
middle frontal gyri, left superior frontal gyrus, right superior parietal 
lobule and right cerebellum exterior. Moreover, we showed that atrophy 
in right cerebellum exterior was more pronounced in patients than 
controls and can thus be considered MS-specific. The spatiotemporal 
pattern of GM atrophy found in this study is in good accordance with 
findings of MS atrophy studies (e.g., Eshaghi et al., 2018; Pagani et al., 
2005; Bendfeldt et al., 2009), especially when the difference in regional 
GM volume between patients and controls is considered independent of 
the impact of time (Fig. S2). 
Fig. 3. Neural network activity and future GM atrophy. (a) Matrices showing the correlation of activity for the pairs of regions included in the neuroanatomical 
atlas separately for resting and stress stage. (b) Activity of neural stress networks during stress and resting stage and differential activity between these two con-
ditions. (c) Significant association between differential stress activity of the 18th network and longitudinal GM volume loss in the right superior parietal lobule and 
between differential activity of the 22nd network and volume loss in the right cerebellum exterior. Longitudinal volume loss of both regions was corrected for 
covariates of no interest (see section 2.5.3 for details). (d, e) Brain regions included in the atlas with a significant link to the two networks as determined by a 
permutation test (see supplementary methods for details). 
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In the second analysis, we tested whether psychological stress pre-
dicts future atrophy in the five areas revealed by the first analysis and 
found that atrophy in right superior parietal lobule could be predicted. 
Importantly, stronger feelings of being stressed by the task were coupled 
to less future atrophy. This finding of a detrimental effect of psycho-
logical stress insensitivity for disease processes is compatible with a 
positive link between HPA-axis activity in pharmacological challenge 
tasks and future EDSS in pwMS (Gold et al., 2005; Kern et al., 2013). 
Additionally, it fits well to the negative cross-sectional link between 
stress-induced brain activity and clinical disability and atrophy found in 
pwMS in (Weygandt et al., 2016). 
In the third analysis, we tested whether stress-induced neural 
network activity predicts future atrophy in the five GM areas identified 
in pwMS in the first analysis and found that activity of two networks 
(Wang et al., 2005; Wager et al., 2005) predicted regional GM volume 
loss of two GM areas. Together, (i) the specific areas contributing to both 
networks and (ii) the association between activity of the 18th network 
and salivary cortisol shown in the Supplement (although this should be 
interpreted carefully due to the small number of samples available in 
this supplementary analysis), these findings argue that glucocorticoids 
might contribute to the link between stress-induced brain activity and 
future MS atrophy. Specifically, activity of a network primarily con-
sisting of prefrontal cortex areas was negatively related to longitudinal 
volume loss in the right superior parietal lobule. The areas contributing 
to this network are compatible with stress-sensitive prefronto-regions 
found in an fMRI stress study by Wang et al. (2005) and even more so 
with a study by (Urry et al., 2006) who showed a regulatory function of 
these areas for daytime cortisol release. Notably, this network also 
comprised the basal forebrain, a key area of the cholinergic systems 
(Paul et al., 2015) which can stimulate glucocortcicoid release by the 
HPA axis (see below). Activity of the second network which primarily 
comprised limbic brain regions (i.e., amygdala, ventral diencephalon 
[which includes the hypothalamus], enthorinal cortex, anterior cingu-
late cortex, orbitofrontal gyri, and gyrus rectus) was negatively related 
to longitudinal volume loss in the right exterior cerebellum. Limbic 
areas are the key regulators of glucocorticoid release by the HPA axis 
(Urry et al., 2006). 
Interestingly, a longitudinal association of glucocorticoid-related 
brain activity and GM loss is consistent with findings of cross-sectional 
studies in healthy subjects demonstrating a positive link between 
cortisol release after dexamethasone application and ventricular volume 
(Schumann et al., 2002). Moreover, a contribution of the basal forebrain 
to atrophy predictive networks is also in line with a 
glucocorticoid-related explanation of MS atrophy as stress-induced 
choline release in this area can subsequently stimulate the HPA axis 
(Paul et al., 2015). 
Several studies have proposed explanations for mechanisms under-
lying stress and glucocorticoid mediated neurodegeneration. Specif-
ically, animal studies showed that chronic stress leads to permanent loss 
of dendrites in the rat prefrontal cortex (Radley et al., 2006) and that 
sustained and excessive glucocorticoid release in mice provokes 
increased loss of stable dendritic spines developed early in life (Liston 
and Gan, 2011). Thus, considering that the GM signal measured with 
T1-weighted MRI sequences does not solely account for cell bodies but 
also dendrites (Zatorre et al., 2012), dendritic loss induced by excess 
glucocorticoid availability (common in MS; Michelson et al., 1994) 
could be a predictable measure of GM loss in MS in this study. 
Finally, in the fourth analysis, we tested the association between 
atrophy-predictive network activity and psychological stress and found 
that network activity predictive of right superior parietal lobule atrophy 
was positively related to perceived stress. Together, the findings that 
psychological (second analysis) and neural stress processing (third 
analysis) were negatively related to atrophy of this area and that they 
showed a positive mutual correlation (this analysis) strengthen our 
above interpretation that blunted neurocognitive stress processing has a 
detrimental effect on the course of MS. Please note that this presumably 
also holds for the link between limbic network activity and cerebellar 
atrophy – at least if one takes i. the negative link of amygdala CBF and 
activity of this network (Fig. 3d) and ii. the positive link of the network’s 
activity and atrophy as guiding principle since amygdala activity is 
positively linked to cortisol release (Urry et al., 2006). 
Importantly, blunted affective processing in MS has been reported by 
several other studies. For example Kleeberg et al. (2004), showed with a 
decision-making task that necessitates the perception of learned 
emotional arousal preceding (and putatively preventing) a negative 
choice that this affective learning process (i.e., an increase of anticipa-
tory skin conductance during poor options) was much weaker in patients 
than controls. Consistently, we could show using an fMRI version of this 
task that activity in ventromedial prefrontal/orbitofrontal areas (i.e., the 
regions coding for and regulating these so-called somatic-markers) was 
positively linked to the task performance of pwMS and HCs. Simulta-
neously both parameters, performance and activity, were lower in pa-
tients (Weygandt et al., 2018). 
Several aspects of the study warrant further discussions. The fact that 
the joint availability of fMRI stress data acquired at T0 and longitudinal 
GM volume data covering T0 and T1 was only given for pwMS is a major 
limitation of this work as this complicates an assessment of whether 
stress-based predictability of longitudinal atrophy is MS-specific or 
rather a more global, generic phenomenon. Consequently, we conducted 
two steps/analyses to address this potential weakness. First, we tested in 
the second subanalysis included in ‘2.5.1 Analysis of longitudinal GM 
volume loss’ whether the volume loss of areas identified in the MS- 
specific first subanalysis of 2.5.1 was more pronounced in MS than the 
sMRI control group and thus whether longitudinal volume loss had an 
MS-specific dynamic in these regions. This revealed that this was the 
case for the right exterior cerebellum. Second, we conducted a supple-
mentary analysis of stress network activity differences between patients 
and controls based on the fMRI data of pwMS and the fMRI control 
group. This showed that none of the two neural networks predictive of 
atrophy in pwMS was characterized by hyper- or hypoactivity in pwMS 
compared to HCs. Together, these findings suggest that future regional 
volume loss (partially) specific for MS (i.e., in exterior cerebellum) is 
preceded by specific patterns of stress-evoked activity in MS but that it is 
not the activity that directly drives volume loss but that (unknown) 
additional MS-specific factors linked to stress-evoked brain activity 
heighten the vulnerability of neural tissue to processes regulated by/ 
Fig. 4. Neural network activity and perceived stress. (a) The scatterplot on 
the left depicts the association between activity of the 18th network (also 
predictive of longitudinal GM atrophy of right superior parietal lobule) and the 
difference between the post- and the pre-stress stage (corrected for covariates of 
no interest). In (b) we again depict the brain regions contributing to (activity 
of) network 18 for better comprehensibility. 
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attached to this activity in MS. 
Another point necessitating further notice is the difference in stress 
responses across measures evaluated. Except for one marker, each 
parameter (i.e., heart rate, subjective stress ratings, and neural networks 
comprising key stress processing regions) indicated a clear stress 
response. However, it should be noted that the task did not elicit a 
pronounced HPA response. This finding might be explained by two 
factors. First, it is known that stress tasks without a strong social eval-
uative component (e.g., without public speaking) sometimes fail to elicit 
such a response (see Michelson et al. (1994) for an overview) and even 
when a strong evaluative component is included, a marked HPA 
response is not guaranteed (Dimitrov et al., 2018). Second, results of 
Dimitrov et al. (2018) and Muehlhan et al. (2011) suggest that an MRI 
session can act as a potent stressor/trigger for cortisol release indepen-
dent of the stimuli applied and that this stressor can trigger a maximal 
cortisol release at session onset which is followed by a continuous 
decline across the session – which exactly describes the cortisol trajec-
tories observed here. Consequently, it is possible that the cortisol release 
triggered by MRI scanning onset concealed a weaker task-induced 
cortisol response. 
A final aspect that should be critically discussed is that of potential 
confounding factors that might drive the link between neural stress 
processing and future atrophy. In line with findings of Kennedy and 
Scholey (2000) showing that inter-participant response differences in 
typical stress measures during a mental arithmetic task such as heart rate 
might simply reflect differences in functioning of a cardiac mechanism 
aiming to adopt brain glucose delivery to differences in cognitive 
effort/metabolic demands, variations in task load might be a factor 
coming into one’s mind at this point. However, given that all analyses in 
this work relying on functional stress-response measures (2.5.2, 2.5.3, 
2.5.4, and the supplementary analysis of psychophysiological stress task 
responses) included task load as covariate of no interest in the respective 
linear regression models to capture the impact of this factors, this pos-
sibility appears highly unlikely. Other conceivable confounding factors 
might comprise alternative MS-related mechanisms. Again, however, 
this appears unlikely in the context of this work. Firstly, development of 
new brain lesions in a time period of one year prior to fMRI scanning (i. 
e., stress-induction at T0) was very restricted in fifteen MS patients for 
which corresponding T2-weighted images were available for evaluation 
(cf. Supplement). Secondly, the median number of days between last 
relapse and T0 across all patients was 657 days. Thirdly, voxel co-
ordinates containing lesions at T0 were not evaluated in computation of 
neural network activity. Fourthly, volume of each GM region at T0 was 
included as covariate of no interest in analyses modelling atrophy be-
tween T0 and T1 for that region. Together, these factors suggest that 
potential alternative MS-related mechanisms did not have an essential 
impact on the association between neural stress network activity at T0 
and future GM atrophy. 
In conclusion, when considering that neural (Sinha et al., 2016) and 
psychological (Mohr et al., 2012) stress processing can be modified 
through cognitive interventions, and given the relevance of parietal 
(Sepulcre et al., 2009; Hanken et al., 2016) and cerebellar (Cocozza 
et al., 2017; D’Ambrosio et al., 2017) pathology for MS, stress processing 
might constitute a modifiable disease factor of high clinical importance. 
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